Parametrica Management LTD Sorrento Therapeutics, Inc. Transaction History

Parametrica Management LTD

  • $83.5 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022
SELL
$1.24 - $2.33 $46,359 - $87,111
-37,387 Closed
0 $0
Q1 2022

May 10, 2022
BUY
$2.0 - $4.9 $74,774 - $183,196
37,387 New
37,387 $87,000
Q4 2021

Feb 15, 2022
SELL
$4.65 - $7.23 $51,419 - $79,949
-11,058 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$7.41 - $10.99 $81,939 - $121,527
11,058 New
11,058 $84,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Parametrica Management LTD Portfolio

Follow Parametrica Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email